Stockscreener 앱 받기
8.07
7.74%
0.58
시간 외 거래:
8.12
0.05
+0.62%
전일 마감가:
$7.49
열려 있는:
$7.49
하루 거래량:
99,944
Relative Volume:
0.03
시가총액:
$18.07M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
-0.8585
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
+10.25%
1개월 성능:
-49.69%
6개월 성능:
+36.72%
1년 성능:
-56.52%
1일 변동 폭
$7.49
$8.3242
1주일 범위
$7.15
$8.3242
52주 변동 폭
$0.215
$39.84
Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile
명칭
Cyclacel Pharmaceuticals Inc
전화
908-517-7330
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
CYCC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CYCC
Cyclacel Pharmaceuticals Inc
|
8.07 | 16.77M | 74,000 | -13.43M | -10.54M | -9.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-04-27 | 재개 | ROTH Capital | Buy |
| 2018-09-07 | 개시 | Ladenburg Thalmann | Buy |
| 2015-10-16 | 개시 | H.C. Wainwright | Buy |
| 2010-02-04 | 개시 | Roth Capital | Buy |
| 2009-10-28 | 개시 | Merriman | Buy |
| 2008-08-12 | 개시 | Piper Jaffray | Buy |
| 2008-03-12 | 재확인 | Cantor Fitzgerald | Buy |
| 2008-03-12 | 재확인 | Collins Stewart | Buy |
| 2008-03-12 | 재확인 | Needham & Co | Buy |
| 2007-11-27 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-08-10 | 재확인 | Cantor Fitzgerald | Buy |
| 2007-06-04 | 재확인 | Needham & Co | Buy |
| 2007-04-23 | 개시 | Lazard Capital | Buy |
| 2007-04-10 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스
Cyclacel Pharmaceuticals Inc. stock prediction for this weekPortfolio Risk Report & Comprehensive Market Scan Insights - Newser
Is Cyclacel Pharmaceuticals Inc. building a consolidation baseJuly 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Understanding Cyclacel Pharmaceuticals Inc.’s price movementOptions Play & Scalable Portfolio Growth Ideas - Newser
Top chart patterns to watch in Cyclacel Pharmaceuticals Inc.Buy Signal & Community Verified Trade Alerts - Newser
What MACD and RSI say about Cyclacel Pharmaceuticals Inc.Oil Prices & Daily Momentum Trading Reports - Newser
Price momentum metrics for Cyclacel Pharmaceuticals Inc. explainedMarket Growth Report & Entry Point Confirmation Alerts - Newser
Signal strength of Cyclacel Pharmaceuticals Inc. stock in tech scannersWeekly Investment Report & Fast Moving Trade Plans - Newser
Using Python tools to backtest Cyclacel Pharmaceuticals Inc. strategiesJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Is Cyclacel Pharmaceuticals Inc. stock poised for growthDividend Hike & Momentum Based Trading Ideas - Newser
Cyclacel Pharmaceuticals Inc. stock volume spike explainedBond Market & Entry Point Confirmation Signals - Newser
News impact scoring models applied to Cyclacel Pharmaceuticals Inc.July 2025 Volume & Capital Efficient Trading Techniques - Newser
Detecting price anomalies in Cyclacel Pharmaceuticals Inc. with AIRate Hike & Safe Capital Growth Trade Ideas - Newser
Using data models to predict Cyclacel Pharmaceuticals Inc. stock movementTreasury Yields & Real-Time Stock Entry Alerts - Newser
How high can Cyclacel Pharmaceuticals Inc. stock go2025 Dividend Review & Community Consensus Trade Signals - Newser
Will Cyclacel Pharmaceuticals Inc. be affected by tariffsJuly 2025 Breakouts & Technical Confirmation Alerts - theviewers.co.kr
Will Cyclacel Pharmaceuticals Inc. stock hit new highs in YEARStop Loss & Free Daily Entry Point Trade Alerts - sundaytimes.kr
Full technical analysis of Cyclacel Pharmaceuticals Inc. stockRate Hike & Growth Oriented Trading Recommendations - Newser
CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT - ADVFN Brasil
How moving averages guide Cyclacel Pharmaceuticals Inc. tradingTrade Exit Report & Weekly Stock Breakout Alerts - Newser
Analyzing recovery setups for Cyclacel Pharmaceuticals Inc. investorsWeekly Trend Recap & Community Verified Swing Trade Signals - Newser
Is Cyclacel Pharmaceuticals Inc. stock forming a cup and handleLayoff News & Fast Entry Momentum Alerts - theviewers.co.kr
Is Cyclacel Pharmaceuticals Inc.’s growth already priced inWeekly Trend Recap & Expert Approved Trade Ideas - theviewers.co.kr
Can Traders Expect Breakout From Cyclacel Pharmaceuticals Inc. This Week2025 Retail Activity & Real-Time Chart Pattern Alerts - 더경남뉴스
Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attention2025 Growth vs Value & Daily Momentum Trading Reports - Newser
Cyclacel Pharmaceuticals Implements Reverse Stock Split in July - MSN
Cyclacel Pharmaceuticals shares fall 1.87% intraday as tech stocks experience a mild correction. - AInvest
Chart overlay techniques for tracking Cyclacel Pharmaceuticals Inc.Market Movement Recap & AI Enhanced Trading Signals - Newser
📊 What is the current market sentiment towards CYCC? - AInvest
Long term hold vs stop loss in Cyclacel Pharmaceuticals Inc.Weekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
What makes Cyclacel Pharmaceuticals Inc. stock price move sharplyJuly 2025 Rallies & AI Powered Market Entry Strategies - Newser
Cyclacel Pharmaceuticals adjusts shareholder rights, amends stock - MSN
Is Cyclacel Pharmaceuticals Inc. still worth holding after the dip2025 Geopolitical Influence & Daily Stock Trend Watchlist - Newser
Historical volatility pattern of Cyclacel Pharmaceuticals Inc. visualized2025 Sector Review & Stock Portfolio Risk Control - Newser
Applying chart zones and confluence areas to Cyclacel Pharmaceuticals Inc.2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
Reversal indicators forming on Cyclacel Pharmaceuticals Inc. stockJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Will Volume Confirm Reversal in Cyclacel Pharmaceuticals Inc.2025 Trading Volume Trends & Weekly Setup with High ROI Potential - sundaytimes.kr
Published on: 2025-08-16 06:26:36 - Newser
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Upgraded at Wall Street Zen - Defense World
Visualizing Cyclacel Pharmaceuticals Inc. stock with heatmapsJuly 2025 Highlights & AI Driven Price Predictions - Newser
Published on: 2025-08-15 20:31:40 - Newser
Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Cyclacel Pharmaceuticals Inc 주식 (CYCC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lazar David E. | Interim CEO |
Feb 26 '25 |
Sale |
0.03 |
194,628,820 |
5,507,996 |
0 |
0.98%
8.06%
자본화:
|
볼륨(24시간):